Clinical trials: Bechet's Disease
Bechet's Disease
Expanded Access for CC-10004
This is an expanded access program (EAP) for eligible participants designed to provide access to CC-10004.
- Trial name
- NCT03740516
- Testing
- CC-10004
- Where
- United States
- Sponsor
- Amgen
Behcet's Syndrome, Retinal Disease
HAT in Eye Complications of Behcet's Disease
This study will evaluate the safety and effectiveness of Zenapax in controlling recurrent eye inflammations associated with Behcet's disease. Behcet's disease is usually treated with corticosteroids to suppress inflammation.
- Conditions
- Behcet's Syndrome, Retinal Disease, Uveitis
- Trial name
- NCT00001865
- Testing
- Daclizumab
- Where
- United States
- Volunteers
- 26 people
- Sponsor
- National Eye Institute (NEI)
Bechet's Disease
A Long-term Study of HSK44459 Tablets in Participants With Bechet's Disease
This is a long-term extension study of HSK44459-202 in eligible participants who have completed the Week 12 visit of the originating Study HSK44459-202.
- Trial name
- NCT07070739
- Testing
- HSK44459 tablets
- Volunteers
- 120 people
- Sponsor
- Haisco Pharmaceutical Group Co., Ltd.